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Beta-ketothiolase deficiency is a rare autosomal recessive disorder 
characterized by an inborn error of isoleucine catabolism and affecting 
ketone body metabolism. Clinical features characterized by intermittent 
keto acidotic episodes are associated with clinical signs and symptoms of 
toxic encephalopathy such as lethargy, hypotonia, vomiting, tachypnea, 
and coma in some patients, with an onset during infancy or toddler-hood. 
A two months old girl presented to pediatric ward of Imam Reza Hospital 
in Mashhad City, Northwestern Iran in October 2016, with acute episode 
of fever and toxic encephalopathy with attack of vomiting, hypotonia, 
lethargy, tonic-clonic seizures and then a day in coma, few days after 
vaccination. After then similar episodes happened until 7 months age. Bio 
chemical tests that suggested diagnose of beta ketothiolase deficiency were 
attacks of ketoacidosis with urinary exertion of 2-methyl-3-hydroxybutyric 
acid 2-methyl aceto acetic acid tiglylglycine. In genetic assessment, we 
detected a novel homozygous mutation c.664A> C (p. Ser 222 Arg) in 
ACAT gene. This is the first report of beta ketothiolase deficiency 
confirmed by molecular analysis from Iran. We report on a homozygous 
variant in the ACAT1 gene and that is a novel mutation. We recommended 
carrier testing for all informative family members to recognize mutations 
in asymptomatic family members.
Keywords: Beta-ketothiolase deficiency; encephalopathy like symptoms; 
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Introduction
Beta-ketothiolase deficiency also known as alpha-methyl acetoacetic 
aciduria, T2 deficiency, mitochondrial acetoacetyl-CoA thiolase deficiency, 
3-oxothiolase deficiency and 2-methyl-3-hydroxybutyric acidemia (1-4).
The T2 deficiency (as an abbreviation of beta-kethothiolase deficiency) is an 
autosomal recessive organic aciduria due to the deficiency of mitochondrial 
beta ketothiolase enzyme affected in pathway of ketone body metabolism 
and isoleucine catabolism (Figure 1) (5, 6). 
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Currently, more than 100 patients have been 
reported worldwide with no local predisposition 
(1). This rare condition is estimated with an 
incidence of 1 per 1 million newborns or less (2,7).
This disorder first described in 1971 in 6 years old 
boy. The presenting clinical feature was severe 
episodes of metabolic acidosis with increased 
amounts of alpha-methyl beta- hydroxyl butyric 
acid in the urine (8).
The typical clinical features manifest between 
age of 6 to 18 months in infancy with intermittent 
attacks of ketoacidosis crisis, vomiting, hypotonia, 
respiratory distress, convulsion, and lethargy. 
Coma, psychomotor retraction and even death 
have been reported in rare cases (9). These acute 
crises can decompensate rapidly in early childhood 
and lead to neurodevelopmental delay, repeated 
seizures and death without appropriate treatment 
(10).
The episodes often brought on by stress, fasting, 
acute illness, fever and infection (2). The frequency 
of episodes decreases with age and between 
Figure. 1.Isoleucine 
metabolism and metabolic 
block in T2 (ketothiolase) 
deficiency (5)
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episodes, patients are often asymptomatic. Severity 
of disease varies among patients but outcome can 
be good (11).
In rare cases, atypical presentation can happen with 
having sign and symptoms before age of 6 months, 
even in neonatal period (12), also some patients can 
present with neurological manifestations before a 
first ketoacidotic crises, however, is very rare (13).
This disorder can be suspected with presence 
of keto acidotic attacks, increased urinary 
level of 2-methyl-3-hydroxybutyrate, 2-methyl 
acetoacetate and tiglylglycine witch revealed by 
urinary organic acid analysis and/or increased 
levels of tiglycarnitine and 2-methyl-3-
hydroxybutylcarnitine in blood plasma analysis (1, 
3). Quantitative organic acid analysis can use for 
any patient presenting with attacks of unexplained 
ketoacidosis and clinical symptoms of hypotonia, 
seizure, motor or mental delay of unknown 
cause (2, 3). According to clinical phenotype and 
distinctive laboratory finding, genetic assay can 
help for confirming the diagnosis by ACAT1 gene 
mutation analysis (14).
Early diagnosis of T2 deficiency especially in 
asymptomatic cases and appropriate management 
will prevent its serious complications and improve 
final prognosis (2).
Case Presentation
A two months old Iranian girl born to consanguineous 
parents (cousin), presented in our center (Imam 
Reza Hospital, Mashhad, Iran) in October 2016 for 
evaluation of seizure and hypotonia in Pediatric 
Department. She had one sibling who died in 7 
months old with similar symptoms and no more 
specific metabolic assessment.
Her mother had pregnancy-induced hypertension. 
She was a full term baby with birth weight of 2500 
gr, birth length of 45 cm, birth head circumference 
of 32 cm and normal APGAR score.
She admitted at hospital in the fifth day of life with 
chief complaint of neonatal jaundice. In her first 
presentation at 2 months old, she had a history 
of fever, poor feeding and vomiting for 2d after 
routine vaccination. Her condition deteriorated 
with tonic-clonic seizures, difficulties in breathing, 
severe restlessness, lethargy, hypotonia and come 
for 1 day in her admission in intensive care unit. 
After first admission, she had four more episodes 
with similar signs and symptoms and between these 
crises; she was asymptomatic. Developmentally, at 
8 months, she could not babble, have head drop. She 
could not sit with support. Physical examination 
revealed no organomegaly. Not hearing or visual 
abnormalities.
Neurological examination results showed 
hypotonia and decreased deep tendon reflexes.
Arterial Blood Gas test revealed metabolic acidosis 
with PH: 7.2, HCO3: 5mmol/L, base excess: -20, 
and pCO2: 12.5 mmHg in her first acute attack. 
High level of blood sugar and ketonuria was 
detected. The patient’s plasma showed normal 
Ammoniae (72 µmol/L) and lactate (11 mg/dl). 
Beside negative Urine and blood culture, serum 
electrolytes, liver and renal and thyroid function 
tests had normal results. CSF analysis revealed 
negative results for infection.
Brain Magnetic Resonance Imaging (MRI) 
showed unspecific low signal intensity basal 
ganglia (Figure 2). Tandem mass spectrometry 
(MS/MS) showed hydroxy methylglutaryl CoA-
lyase deficiency and 3- methyl coronyl– coalyase 
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deficiency. Suggested diagnosis was beta keto-
thiolase deficiency (oxothiolase deficiency).
The organic acids in her urine showed an elevated 
2methyl -3hydroxybutiric acid, an elevated 
tiglyglycine and 4 – hydroxy phenyl lactic acid.
Patient referred to gene assay diagnosis by whole 
exome sequencing examination. Approximately 
37 MB (214,405 exons) of the Consensus Coding 
Sequences (CCS) were enriched from fragmented 
genomic DNA and were evaluated by Centogene 
AG Department. In genetic assay, we found a novel 
homozygous mutation c.664A>C (p. ser 222Arg) 
in ACAT1 gene that was the first time we detect 
this variant (Table 1). 
Figure. 2. Brain Magnetic Resonance Imaging shows nonspecific low signal intensity in basal 
ganglia 










Hom. Not described Alpha-methylacetoacetic aciduria (203750, AR)
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These results were consistent with a genetic 
diagnosis of beta-ketothiolase deficiency (alpha-
methyl acetoacetic aciduria) in our patient. 
Discussion
Beta ketothiolase deficiency is a rare disease that 
affects isoleucine catabolism and ketone body 
utilization. The common age of onset is between 
6 and 24 months. It is clinically characterized 
by acute attacks of ketoacidosis with vomiting, 
dehydration, lethargy, and seizure that can trigger 
with infection, stress and fasting (2, 5). T2 
deficiency can be considered in the differential 
diagnosis for ketoacidosis in children without 
marked reason (15).
In this case report, we described a 2-month 
old girl with Beta-ketothiolase deficiency who 
initially presented with seizure, hypotonia, and 
hyporeflexia. In other reports, the first presentation 
varies from neonatal age to childhood. In Libya, 
there is a report of 2 siblings with T2 deficiency 
with different first presentation in 7 months 
age and 4 yr old age, that shows the various age 
presentation even in a family (3,15).
Patients commonly have clinical presentation of 
metabolic encephalopathy like vomiting, seizures, 
and loss of consciousness(15) which could astound 
the correct diagnosis.
As mentioned this disorder can be suspected with 
presence of keto acidotic attacks, increased urinary 
level of 2-methyl-3-hydroxybutyrate,2-methyl 
acetoacetate and tiglylglycine witch revealed by 
urinary organic acid analysis and/or increased levels of 
tiglycarnitine and 2-methyl-3-hydroxybutylcarnitine 
in blood plasma analysis (1, 3).
This disorder can be diagnosed in prenatal period, 
but it can manifest rarely during neonatal period 
(3). New born screening programs (NBS programs) 
can detect beta-ketothiolase deficiency in first few 
days of life, before appearance of clinical features; 
however, some developing countries may not 
have this routine screening (2). In addition, some 
patients cannot be detected by metabolic screening, 
so true incidence of beta ketothilase deficiency 
is uncertain. More than 100 patients have been 
reported from different countries (1). The first 
report of our country was a 6 month-old Iranian boy 
presented with clinical symptoms and diagnostic 
urinary organic acid analysis for beta -ketothiolase 
deficiency. Genetic assay was not reported for 
this case (16). We do not have clear incidence in 
Iran, but in three Middle East countries to be 1.4, 
1.6 and 2.76 per 100000 newborn in Qatar, Saudi 
Arabia and United Arab Emirates (17-19).
T2 deficiency can be confirmed by mutation in 
ACAT1 gene in DNA genomic analysis (2). First 
time, 2 mutations in ACAT1 gene were found, that 
it was the first definition of a mutant ACAT allele 
and the diagnosis of beta ketothiolase deficiency 
was made by urinary organic acid analysis (20). 
ACAT gene is located on chromosome 11q 22.3 
to q23.1 is 27-kb in length and contains 12 exons 
and 11 introns (20). Today there are more than 
70 different mutations resulting beta ketothiolase 
deficiency in different population and few novel 
mutations have been reported worldwide (2, 15). 
In a descriptive study of 35 patients with T2 
deficiency in Vietnam, the most common mutation 
of ACAT1 gene was R208X (p.Arg208) in 70% of 
cases, that it is the most common mutation has been 
identified in the world (21). Except this mutation 
in Vietnamese (p.Arg208), no other common 
ACAT1 mutations have been reported (15). In 
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Asian and Arab countries, there are some reports of 
ACAT1 mutations and novel mutations (Table.2) 
(17, 22-26). In our study, we found a homozygous 
mutation c.664A>C (p. ser 222Arg) in ACAT1 
gene by whole exome sequencing test, that was a 
novel mutation, so it has not been reported before.
Today, the DNA analysis of suspected gene in 
patients with beta ketothiolase deficiency can 
confirm this disorder. In gene, analysis reveal 
novel variants in ACAT1 gene that have never 
been reported, can be enough for diagnosis of beta-
ketothiolase deficiency (7, 26). Furthermore, in 
2-methyl 3hydroxybutyryl- COA dehydrogenase 
deficiency, the biochemical profile may mimic 
the beta -ketothiolase deficiency disorder, so 
a genetic analysis of ACAT1 gene can help to 
confirm the diagnosis (15). In patients with beta-
ketothiolase deficiency, early diagnoses and proper 
management can make a favorable outcome. In 
addition, screening of other family members with 
genetic counseling can identify asymptomatic 
members. In addition, a prenatal diagnosis can 
be useful consideration in early diagnosis and 
management in patients, but clinical manifestations 
in neonatal period are rare (3). Recurrent attacks of 
ketoacidosis, biochemical findings, and mutation 
analysis of ACAT1 gene, the diagnosis of beta-
ketothiolase deficiency correlated with our patient. 
With the proper management, our patient is in a 
good condition without any acute episode in recent 
2 months.
In conclusion, in patients with beta-ketothiolase 
Table 2. Gene mutation analysis in beta-ketothiolase deficiency in Asian and Arab population











Vietnam Case series p.Arg208
India Case report c.578T>G
Lebanese origin Case report (novel) c.1124A>G
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deficiency early diagnose and proper management 
can make a favorable outcome. In addition, 
screening of other family members with genetic 
counseling can provide the asymptomatic members. 
Moreover, a prenatal diagnosis can be useful 
consideration in early diagnosis and management.
Because of the vast clinical spectrum of beta-
ketothiolase deficiency, and preventive treatment 
can decrease or omit the incident of metabolic 
crises, our suggestion would be screening of 
patient’s siblings even if they are asymptomatic 
and have no history of keto acidotic crises.
On the other hand, challenge of subtle abnormalities 
in urinary organic acid profile and the necessity of 
early exact diagnosis emphasis on using genetic 
assay or an enzymatic analysis to confirm the 
diagnosis.
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